Met Life Investment Management, LLC Geron Corp Transaction History
Met Life Investment Management, LLC
- $17.1 Billion
- Q3 2024
A detailed history of Met Life Investment Management, LLC transactions in Geron Corp stock. As of the latest transaction made, Met Life Investment Management, LLC holds 323,659 shares of GERN stock, worth $922,428. This represents 0.01% of its overall portfolio holdings.
Number of Shares
323,659
Previous 332,762
2.74%
Holding current value
$922,428
Previous $1.41 Million
4.18%
% of portfolio
0.01%
Previous 0.01%
Shares
70 transactions
Others Institutions Holding GERN
# of Institutions
276Shares Held
491MCall Options Held
1.87MPut Options Held
690K-
Black Rock Inc. New York, NY46.6MShares$133 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY44.1MShares$126 Million3.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA32.4MShares$92.5 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA32.3MShares$92 Million2.04% of portfolio
-
State Street Corp Boston, MA29MShares$82.5 Million0.01% of portfolio
About GERON CORP
- Ticker GERN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 377,819,008
- Market Cap $1.08B
- Description
- Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...